Study Assessing Risk Factors for Abdominal Pain in Children With Inflammatory Bowel Disease
NCT02984059 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 126
Last updated 2019-02-08
Summary
To characterize persistent abdominal pain in children with inflammatory bowel disease (IBD) by examining factors such as disease type, activity and location, psychosocial factors, and genetics.
The investigators hypothesize that by using patient pain and psychological assessments in addition to analysis of blood, stool and colonic biopsies, we can better characterize factors that predispose children and adolescents with IBD to have persistent and/or disproportionate abdominal pain.
Conditions
Interventions
- GENETIC
-
Genomic DNA
blood draw
- GENETIC
-
RNA analysis
Mucosal Biopsy via colonoscopy
- GENETIC
-
Microbiome
Stool microbiome
- OTHER
-
Calprotectin
stool or blood analysis for calprotectin
- OTHER
-
Pain questionnaires
PSDS PCS-C/P PBI APPT
- OTHER
-
Anxiety/Depression Questionnaires
RCADS-25 CSI-24 ARCS
Sponsors & Collaborators
-
Connecticut Children's Medical Center
lead OTHER
Principal Investigators
-
Victoria Grossi, DO · Connecticut Children's Medical Center
Eligibility
- Min Age
- 8 Years
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-21
- Primary Completion
- 2018-08-01
- Completion
- 2018-08-01
Countries
- United States
Study Locations
More Related Trials
-
Infliximab to Treat Crohn'S-like Inflammatory Bowel Disease in Chronic Granulomatous Disease
NCT00325078 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Medication Adherence in Patients With Inflammatory Bowel Disease (IBD)
NCT02620514 ·Status: COMPLETED ·Phase: NA
-
A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease
NCT00606346 ·Status: ACTIVE_NOT_RECRUITING
-
Adalimumab Trough Concentrations in Crohn's Disease: A Pilot Pharmacokinetic Study
NCT02450513 ·Status: COMPLETED
-
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
NCT03251118 ·Status: ACTIVE_NOT_RECRUITING
-
Real-World Study on the Safety and Effectiveness of IL-23 Inhibitors for Inflammatory Bowel Disease in China
NCT07184138 ·Status: NOT_YET_RECRUITING
-
Quality of Life in Pediatric Inflammatory Bowel Disease
NCT00061737 ·Status: COMPLETED
-
Study of the Psychometric Properties of Two Questionnaires for Measuring Disease Flare-up in IBD
NCT06214299 ·Status: NOT_YET_RECRUITING
-
Peer Mentoring to Improve Self-management in Youth With IBD
NCT03827109 ·Status: TERMINATED ·Phase: NA
-
Clinical Characteristics and Risk Factors of Children Suffering From Inflammatory Bowel Diseases At Assiut University Children Hospital
NCT05002166 ·Status: RECRUITING
-
Immune Regulation in Ulcerative Colitis or Crohn s Disease
NCT00001184 ·Status: RECRUITING
-
The Role of Gut Microbiome in Predicting Comorbidities and Complications in Children With Inflammatory Bowel Disease
NCT05652491 ·Status: WITHDRAWN
-
Non Invasive Characterization of Pediatric Inflammatory Bowel Diseases Using Multispectral Optoacoustic Tomography
NCT04650867 ·Status: COMPLETED
-
A Self-compassion Intervention for Parents of Children With Inflammatory Bowel Disease (IBD)
NCT04717284 ·Status: COMPLETED ·Phase: NA
-
Impact of a Biofeedback Intervention on Microbiome, Metabolome, and Clinical Outcomes in Pediatric IBD (Study 2)
NCT04296110 ·Status: TERMINATED ·Phase: NA
-
Exacerbating Factors in Inflammatory Bowel Disease
NCT01405105 ·Status: COMPLETED
-
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
NCT00409682 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Ulcerative Colitis
NCT02065557 ·Status: COMPLETED ·Phase: PHASE3
-
Bowel Sounds Analysis in Paediatric Inflammatory Bowel Disease: Relationship With wPCDAI
NCT05955963 ·Status: UNKNOWN ·Phase: NA
-
A Trial for Prevention of Loss of the Effect of Biological Drugs in Patients With Inflammatory Bowel Disease
NCT03843697 ·Status: UNKNOWN ·Phase: NA
-
Mechanism of Chronic Pain in Patients With IBD
NCT04995224 ·Status: RECRUITING
-
Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions
NCT02738125 ·Status: COMPLETED
-
Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics
NCT02316678 ·Status: COMPLETED
-
Therapeutic Endpoint in Pediatric IBD Conditions
NCT06065228 ·Status: RECRUITING
-
Long-term Safety and Efficacy Study of Adalimumab in Pediatric Subjects With Ulcerative Colitis
NCT02632175 ·Status: COMPLETED ·Phase: PHASE3